Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
13/08/2025
US Treasury Secretary Mnuchin: "The Federal Reserve has fundamental issues."
Latest
2 m ago
The US tariff revenue soared to $28 billion in July, but it was unable to prevent the monthly deficit from approaching $300 billion.
4 m ago
CITIC Construction Investment: Margin trading balance surpasses 2 trillion, operating in a healthy and active state
4 m ago
CITIC Securities: Domestic robots are blooming, we continue to be optimistic about the overall sector's market situation.
7 m ago
Non-standard trusts are expected to fully implement diversified investment strategies, and the single financing model is about to come to an end.
8 m ago
The weight loss drug of Eli Lilly and Company performed disappointingly in a key trial, after which the company's CEO, David Ricks, and other insiders bought a total of nearly $3 million worth of stock in subsequent stock sales. Eli Lilly's CEO, David Ricks, purchased $1 million worth of the company's stock on Tuesday. Following disappointing trial data for Eli Lilly's weight loss drug and a subsequent drop in stock price, several executives and board members of Eli Lilly saw an opportunity to buy. According to documents submitted to the Securities and Exchange Commission, five insiders at Eli Lilly collectively purchased $2.9 million worth of stock in the past few days. These insiders include Eli Lilly's CEO, David Ricks, who purchased slightly over $1 million worth of stock on Tuesday.
See all latest